| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and President
1 company
Murdoch Travis is a CEO and President at BRVE. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $52.9M at current prices.
Murdoch Travis's largest disclosed position is in BRVE as CEO and President, worth about $52.9M. Net of sales, the recent Form 4 record there shows accumulation of 83,333 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. Common Stock | CEO and President | Buy | 83,333 | $18.00 | $1,499,994.00 | +2.9% |